Nature Neuroscience, volume 26, issue 6, pages 1032-1041

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

Moliner Rafael 1, 2
Girych Mykhailo 3
Brunello Cecilia 2
Kovaleva Vera 4
Biojone Caroline 2, 5, 6
Enkavi Giray 3
Antenucci Lina 7
Kot Erik F 8, 9
Goncharuk Sergey A. 8, 9
Kaurinkoski Katja 2
Kuutti Mirjami 2
Fred Senem Merve 2
Elsilä Lauri V 1
Sakson Sven 4
Diniz Cassiano 10
Seiffert Nina 2
Rubiolo Anna 11
Haapaniemi Hele 2
Meshi Elsa 12
Nagaeva Elina 1
Öhman Tiina 4
Róg Tomasz 3
Kankuri E. 1
Vilar M. 13
Varjosalo M. 4
Korpi E. R. 1
Permi Perttu 7, 14, 15
Mineev Konstantin S. 8, 9, 16
Saarma Mart 4
Vattulainen Ilpo 3
10
 
Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil
12
 
Biomedical Sciences, Hellenic University of Thessaloniki, Thessaloniki, Greece
13
 
Molecular Basis of Neurodegeneration Unit, Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain
16
 
Institute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Johann Wolfgang Goethe University, Frankfurt am Main, Germany
Publication typeJournal Article
Publication date2023-06-05
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor25
ISSN10976256, 15461726
General Neuroscience
Abstract

Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. We recently reported that pharmacologically diverse antidepressants, including fluoxetine and ketamine, act by binding to TrkB, the receptor for BDNF. Here we show that lysergic acid diethylamide (LSD) and psilocin directly bind to TrkB with affinities 1,000-fold higher than those for other antidepressants, and that psychedelics and antidepressants bind to distinct but partially overlapping sites within the transmembrane domain of TrkB dimers. The effects of psychedelics on neurotrophic signaling, plasticity and antidepressant-like behavior in mice depend on TrkB binding and promotion of endogenous BDNF signaling but are independent of serotonin 2A receptor (5-HT2A) activation, whereas LSD-induced head twitching is dependent on 5-HT2A and independent of TrkB binding. Our data confirm TrkB as a common primary target for antidepressants and suggest that high-affinity TrkB positive allosteric modulators lacking 5-HT2A activity may retain the antidepressant potential of psychedelics without hallucinogenic effects.

Citations by journals

1
2
3
4
5
6
7
Molecular Psychiatry
Molecular Psychiatry, 7, 8.75%
Molecular Psychiatry
7 publications, 8.75%
Neuropsychopharmacology
Neuropsychopharmacology, 4, 5%
Neuropsychopharmacology
4 publications, 5%
Pharmacological Reports
Pharmacological Reports, 4, 5%
Pharmacological Reports
4 publications, 5%
Journal of Psychiatric Practice
Journal of Psychiatric Practice, 2, 2.5%
Journal of Psychiatric Practice
2 publications, 2.5%
Frontiers in Pharmacology
Frontiers in Pharmacology, 2, 2.5%
Frontiers in Pharmacology
2 publications, 2.5%
Pharmacology Biochemistry and Behavior
Pharmacology Biochemistry and Behavior, 2, 2.5%
Pharmacology Biochemistry and Behavior
2 publications, 2.5%
European Archives of Psychiatry and Clinical Neuroscience
European Archives of Psychiatry and Clinical Neuroscience, 2, 2.5%
European Archives of Psychiatry and Clinical Neuroscience
2 publications, 2.5%
Journal of Psychopharmacology
Journal of Psychopharmacology, 2, 2.5%
Journal of Psychopharmacology
2 publications, 2.5%
Nature Reviews Neuroscience
Nature Reviews Neuroscience, 1, 1.25%
Nature Reviews Neuroscience
1 publication, 1.25%
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience, 1, 1.25%
Frontiers in Molecular Neuroscience
1 publication, 1.25%
European Neuropsychopharmacology
European Neuropsychopharmacology, 1, 1.25%
European Neuropsychopharmacology
1 publication, 1.25%
Pharmaceutics
Pharmaceutics, 1, 1.25%
Pharmaceutics
1 publication, 1.25%
Expert Opinion on Drug Safety
Expert Opinion on Drug Safety, 1, 1.25%
Expert Opinion on Drug Safety
1 publication, 1.25%
Journal of Psychoactive Drugs
Journal of Psychoactive Drugs, 1, 1.25%
Journal of Psychoactive Drugs
1 publication, 1.25%
Molecules
Molecules, 1, 1.25%
Molecules
1 publication, 1.25%
Comprehensive Psychoneuroendocrinology
Comprehensive Psychoneuroendocrinology, 1, 1.25%
Comprehensive Psychoneuroendocrinology
1 publication, 1.25%
ACS Pharmacology & Translational Science
ACS Pharmacology & Translational Science, 1, 1.25%
ACS Pharmacology & Translational Science
1 publication, 1.25%
Philosophical Psychology
Philosophical Psychology, 1, 1.25%
Philosophical Psychology
1 publication, 1.25%
Personalized Medicine in Psychiatry
Personalized Medicine in Psychiatry, 1, 1.25%
Personalized Medicine in Psychiatry
1 publication, 1.25%
Expert Opinion on Investigational Drugs
Expert Opinion on Investigational Drugs, 1, 1.25%
Expert Opinion on Investigational Drugs
1 publication, 1.25%
Naunyn-Schmiedeberg's Archives of Pharmacology
Naunyn-Schmiedeberg's Archives of Pharmacology, 1, 1.25%
Naunyn-Schmiedeberg's Archives of Pharmacology
1 publication, 1.25%
Neuroscientist
Neuroscientist, 1, 1.25%
Neuroscientist
1 publication, 1.25%
Nature
Nature, 1, 1.25%
Nature
1 publication, 1.25%
Drug Discovery Today
Drug Discovery Today, 1, 1.25%
Drug Discovery Today
1 publication, 1.25%
Pharmaceuticals
Pharmaceuticals, 1, 1.25%
Pharmaceuticals
1 publication, 1.25%
Journal of Neuroscience
Journal of Neuroscience, 1, 1.25%
Journal of Neuroscience
1 publication, 1.25%
Annales Pharmaceutiques Francaises
Annales Pharmaceutiques Francaises, 1, 1.25%
Annales Pharmaceutiques Francaises
1 publication, 1.25%
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery, 1, 1.25%
Nature Reviews Drug Discovery
1 publication, 1.25%
Biology
Biology, 1, 1.25%
Biology
1 publication, 1.25%
1
2
3
4
5
6
7

Citations by publishers

5
10
15
20
25
Springer Nature
Springer Nature, 25, 31.25%
Springer Nature
25 publications, 31.25%
Elsevier
Elsevier, 14, 17.5%
Elsevier
14 publications, 17.5%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 7, 8.75%
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 8.75%
Frontiers Media S.A.
Frontiers Media S.A., 4, 5%
Frontiers Media S.A.
4 publications, 5%
Taylor & Francis
Taylor & Francis, 4, 5%
Taylor & Francis
4 publications, 5%
American Chemical Society (ACS)
American Chemical Society (ACS), 3, 3.75%
American Chemical Society (ACS)
3 publications, 3.75%
SAGE
SAGE, 3, 3.75%
SAGE
3 publications, 3.75%
Wolters Kluwer Health
Wolters Kluwer Health, 2, 2.5%
Wolters Kluwer Health
2 publications, 2.5%
Wiley
Wiley, 2, 2.5%
Wiley
2 publications, 2.5%
Society for Neuroscience
Society for Neuroscience, 1, 1.25%
Society for Neuroscience
1 publication, 1.25%
Mary Ann Liebert
Mary Ann Liebert, 1, 1.25%
Mary Ann Liebert
1 publication, 1.25%
Annual Reviews
Annual Reviews, 1, 1.25%
Annual Reviews
1 publication, 1.25%
Oxford University Press
Oxford University Press, 1, 1.25%
Oxford University Press
1 publication, 1.25%
5
10
15
20
25
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Moliner R. et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB // Nature Neuroscience. 2023. Vol. 26. No. 6. pp. 1032-1041.
GOST all authors (up to 50) Copy
Moliner R., Girych M., Brunello C., Kovaleva V., Biojone C., Enkavi G., Antenucci L., Kot E. F., Goncharuk S. A., Kaurinkoski K., Kuutti M., Fred S. M., Elsilä L. V., Sakson S., Cannarozzo C., Diniz C., Seiffert N., Rubiolo A., Haapaniemi H., Meshi E., Nagaeva E., Öhman T., Róg T., Kankuri E., Vilar M., Varjosalo M., Korpi E. R., Permi P., Mineev K., Saarma M., Vattulainen I., Casarotto P. C., Castrén E. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB // Nature Neuroscience. 2023. Vol. 26. No. 6. pp. 1032-1041.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41593-023-01316-5
UR - https://doi.org/10.1038%2Fs41593-023-01316-5
TI - Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
T2 - Nature Neuroscience
AU - Moliner, Rafael
AU - Girych, Mykhailo
AU - Brunello, Cecilia
AU - Kovaleva, Vera
AU - Biojone, Caroline
AU - Enkavi, Giray
AU - Antenucci, Lina
AU - Kot, Erik F
AU - Goncharuk, Sergey A.
AU - Kaurinkoski, Katja
AU - Kuutti, Mirjami
AU - Fred, Senem Merve
AU - Elsilä, Lauri V
AU - Sakson, Sven
AU - Cannarozzo, Cecilia
AU - Diniz, Cassiano
AU - Seiffert, Nina
AU - Rubiolo, Anna
AU - Haapaniemi, Hele
AU - Meshi, Elsa
AU - Nagaeva, Elina
AU - Öhman, Tiina
AU - Róg, Tomasz
AU - Kankuri, E.
AU - Vilar, M.
AU - Varjosalo, M.
AU - Korpi, E. R.
AU - Permi, Perttu
AU - Mineev, Konstantin S.
AU - Saarma, Mart
AU - Vattulainen, Ilpo
AU - Casarotto, Plinio C.
AU - Castrén, E.
PY - 2023
DA - 2023/06/05 00:00:00
PB - Springer Nature
SP - 1032-1041
IS - 6
VL - 26
SN - 1097-6256
SN - 1546-1726
ER -
BibTex |
Cite this
BibTex Copy
@article{2023_Moliner,
author = {Rafael Moliner and Mykhailo Girych and Cecilia Brunello and Vera Kovaleva and Caroline Biojone and Giray Enkavi and Lina Antenucci and Erik F Kot and Sergey A. Goncharuk and Katja Kaurinkoski and Mirjami Kuutti and Senem Merve Fred and Lauri V Elsilä and Sven Sakson and Cecilia Cannarozzo and Cassiano Diniz and Nina Seiffert and Anna Rubiolo and Hele Haapaniemi and Elsa Meshi and Elina Nagaeva and Tiina Öhman and Tomasz Róg and E. Kankuri and M. Vilar and M. Varjosalo and E. R. Korpi and Perttu Permi and Konstantin S. Mineev and Mart Saarma and Ilpo Vattulainen and Plinio C. Casarotto and E. Castrén},
title = {Psychedelics promote plasticity by directly binding to BDNF receptor TrkB},
journal = {Nature Neuroscience},
year = {2023},
volume = {26},
publisher = {Springer Nature},
month = {jun},
url = {https://doi.org/10.1038%2Fs41593-023-01316-5},
number = {6},
pages = {1032--1041},
doi = {10.1038/s41593-023-01316-5}
}
MLA
Cite this
MLA Copy
Moliner, Rafael, et al. “Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.” Nature Neuroscience, vol. 26, no. 6, Jun. 2023, pp. 1032-1041. https://doi.org/10.1038%2Fs41593-023-01316-5.
Found error?